Rockwell Medical (RMTI) Total Debt (2013 - 2026)

Rockwell Medical (RMTI) has reported Total Debt for 11 consecutive years, with $9.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Total Debt fell 23.76% year-over-year to $9.0 million; the trailing twelve-month figure through Jun 2026 stood at $9.0 million (down 23.76% YoY), and the FY2025 full-year result was $10.1 million, down 9.19% from the prior year.
• Total Debt was little changed at $9.0 million in Q2 2026 per RMTI's latest filing, from $9.0 million in the prior quarter.
• Across five years, Total Debt topped out at $18.4 million in Q1 2022 and bottomed at $9.0 million in Q3 2023.
• Historically, Total Debt has averaged $11.2 million across 5 years, with a median of $11.0 million in 2023.
• The sharpest annual moves came in 2022 and 2024: Total Debt slumped 55.34% in 2022, then grew 24.15% in 2024.
• Over 5 years, Total Debt stood at $9.2 million in 2022, then grew by 20.15% to $11.0 million in 2023, then gained by 0.67% to $11.1 million in 2024, then decreased by 9.19% to $10.1 million in 2025, then fell by 10.77% to $9.0 million in 2026.
• According to Business Quant data, Total Debt over the past three periods registered $9.0 million, $9.0 million, and $10.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.